A new health education website, HepBsmart.com, sponsored by Gilead
Sciences, Inc., intended for audiences in the United States, is now
online.
Launched last September 7, HepBsmart.com contains
practical information about chronic hepatitis B (CHB), a potentially
life-threatening liver disease that affects an estimated two million
people in the United States and is the leading cause of liver cancer.
Read more
Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Be sure to check out our other blog: Hepatitis & Tattoos
Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment